DAX25.340 +0,3%Est505.993 -0,1%MSCI World4.343 -0,1%Top 10 Crypto12,18 +1,2%Nas23.671 +0,8%Bitcoin77.565 -0,7%Euro1,1678 +0,4%Öl62,89 -0,2%Gold4.585 +1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Novo Nordisk A3EU6F Deutsche Telekom 555750 Bayer BAY001 Allianz 840400 DroneShield A2DMAA TKMS thyssenkrupp Marine Systems TKMS00 Amazon 906866 BASF BASF11 RENK RENK73 Siemens Energy ENER6Y Volkswagen (VW) vz. 766403 Infineon 623100 Lufthansa 823212
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX etwas höher -- US-Ölkonzerne vor Investments in Venezuela -- Eli Lilly plant wohl Abivax-Übernahme -- Novo Nordisk, Goldrekord, Rüstungsaktien, Amazon, DroneShield, Airbus, BYD im Fokus
Top News
Ausblick: JPMorgan Chase legt die Bilanz zum abgelaufenen Quartal vor Ausblick: JPMorgan Chase legt die Bilanz zum abgelaufenen Quartal vor
Aktien von TKMS, Rheinmetall, HENSOLDT & RENK im Blick: Deutsch-indische Rüstungskooperation Aktien von TKMS, Rheinmetall, HENSOLDT & RENK im Blick: Deutsch-indische Rüstungskooperation
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

GRAIL Aktie

Kaufen
Verkaufen
GRAIL Aktien-Sparplan
84,00 EUR -0,80 EUR -0,94 %
FSE
98,00 USD -0,02 USD -0,02 %
vorbörslich
BTT
GRAIL jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.3,34 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA40F8M

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS3847471014

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolGRAL

GRAIL Aktien News

DatumMeistgelesen
PR NewswireGRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
PR NewswireGRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireGRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
Wer­bungGRAIL-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireGRAIL Reports Third Quarter 2025 Financial Results
PR NewswireGRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
PR NewswireGRAIL to Announce Third Quarter 2025 Financial Results
PR NewswireGRAIL, Inc. Announces $325.0 Million Private Placement Financing
PR NewswireGRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Canc...
PR Newswire/U P D A T E -- GRAIL, Inc./
PR NewswireGRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
PR NewswireSamsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
PR NewswireGRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC
PR NewswireGRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
PR NewswireGRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireGRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
PR NewswireGRAIL Reports Second Quarter 2025 Financial Results
PR NewswireGRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
PR NewswireGRAIL to Announce Second Quarter 2025 Financial Results
PR NewswireGRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study
PR NewswireGRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireGRAIL to Present at Jefferies Global Healthcare Conference 2025
PR NewswireGRAIL Reports First Quarter 2025 Financial Results
PR NewswireGRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test
PR NewswireGRAIL to Announce First Quarter 2025 Financial Results
PR NewswireGRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
PR NewswireGRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireGRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
PR NewswireGRAIL to Present at TD Cowen 45th Annual Health Care Conference
PR NewswireGRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
PR NewswireGRAIL to Announce Fourth Quarter 2024 Financial Results
PR NewswireGRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
PR NewswirePatient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
PR NewswireGRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireGRAIL to Participate in Upcoming Investor Conferences
PR NewswireGRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
PR NewswireGRAIL Reports Third Quarter 2024 Financial Results
PR NewswireGRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
PR NewswireGRAIL to Announce Third Quarter 2024 Financial Results
PR NewswireGRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
PR NewswireGRAIL Appoints Sarah Krevans to Board of Directors

GRAIL News

GRAIL News: auf dieser Seite finden Sie alle GRAIL News und Nachrichten zur GRAIL Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch GRAIL News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um GRAIL News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.